Oruka Therapeutics
(NASDAQ) ORKA
Oruka Therapeutics Financials at a Glance
Market Cap
$4.27B
Revenue (TTM)
$0.00
Net Income (TTM)
-$116.25M
EPS (TTM)
-$2.39
P/E Ratio
-29.64
Dividend
$0.00
Beta (Volatility)
0.77 (Low)
Dividend
$0.00
Beta (Volatility)
0.77 (Low)
Price
$72.40
Volume
482,303.027
Open
$73.20
Price
$72.40
Volume
482,303.027
Open
$73.20
Previous Close
$70.88
Daily Range
$70.90 - $74.74
52-Week Range
$10.77 - $91.00
Estimated Earnings Date
Aug 10, 2026
Dividend
$0.00
Beta (Volatility)
0.77 (Low)
Price
$72.40
Volume
482,303.027
Open
$73.20
Previous Close
$70.88
Daily Range
$70.90 - $74.74
52-Week Range
$10.77 - $91.00
Estimated Earnings Date
Aug 10, 2026
ORKA News
ORKA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Oruka Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
68
CEO
Lawrence O. Klein, PhD
Website
www.orukatx.comHeadquarters
Menlo Park, MA, US
ORKA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-27%
Return on Capital
-27%
Return on Assets
-23%
Earnings Yield
-3.37%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.27B
Shares Outstanding
60.31M
Volume
482.30K
Avg. Volume
1.55M
Financials (TTM)
Gross Profit
-$83.00K
Operating Income
-$122.05M
EBITDA
-$105.35M
Operating Cash Flow
-$88.21M
Capital Expenditure
-$209.00K
Free Cash Flow
-$88.42M
Cash & ST Invst.
$337.04M
Total Debt
$1.93M
Oruka Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$43.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$4.27B
N/A
Market Cap/Employee
$152.68M
N/A
Employees
28
N/A
Net Income
-$31.82M
-51.5%
EBITDA
-$31.78M
-51.4%
Quarterly Fundamentals
Total Cash
$388.83M
+11.4%
Total Debt
$1.81M
+90.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$1.13M
+69.7%
Short Term Debt
$680.00K
+140.3%
Return on Assets
-23.04%
N/A
Return on Invested Capital
-27.34%
N/A
Free Cash Flow
-$23.65M
-13.3%
Operating Cash Flow
-$23.58M
-13.0%